GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Other Current Payables

Prestige BioPharma (XKRX:950210) Other Current Payables : ₩15,738 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Other Current Payables?

Prestige BioPharma's Other Current Payables for the quarter that ended in Sep. 2024 was ₩15,738 Mil.

Prestige BioPharma's quarterly Other Current Payables increased from Mar. 2024 (₩15,160 Mil) to Jun. 2024 (₩23,278 Mil) but then declined from Jun. 2024 (₩23,278 Mil) to Sep. 2024 (₩15,738 Mil).

Prestige BioPharma's annual Other Current Payables increased from Jun. 2022 (₩9,970 Mil) to Jun. 2023 (₩15,783 Mil) and increased from Jun. 2023 (₩15,783 Mil) to Jun. 2024 (₩23,278 Mil).


Prestige BioPharma Other Current Payables Historical Data

The historical data trend for Prestige BioPharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma Other Current Payables Chart

Prestige BioPharma Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Other Current Payables
6,699.08 5,714.54 9,969.64 15,782.97 23,278.04

Prestige BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,168.91 15,255.25 15,160.08 23,278.04 15,737.90

Prestige BioPharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Prestige BioPharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of Prestige BioPharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige BioPharma Business Description

Traded in Other Exchanges
N/A
Address
2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222
Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines